http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113376197-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6e77644fb71069b3f6951f945354145 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 |
filingDate | 2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef9e2342bed81faeeb1b9b0a5c5e673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ff74d544896b3f7b02a55a37fcea1d3 |
publicationDate | 2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113376197-A |
titleOfInvention | Nuclear magnetic resonance-based kidney cancer detection system and working method thereof |
abstract | The invention discloses a kidney cancer detection system based on nuclear magnetic resonance and a working method thereof, wherein a nuclear magnetic resonance instrument comprises a selection and measurement unit, a storage unit and a distinguishing unit, wherein the selection and measurement unit is used for measuring at least one nuclear magnetic resonance line in a nuclear magnetic resonance spectrum of a sample in a sample test tube and measuring the line width of the selected resonance line; the storage unit is used for storing a value or a value range; the distinguishing unit is used for distinguishing the measured or derived line width as normal or abnormal according to the information stored in the storage unit. According to the kidney cancer detection system based on nuclear magnetic resonance, when the nuclear magnetic resonance instrument is used for detecting the plasma sample of the patient, the operation is flexible, multiple groups of data can be subjected to system analysis data, the workload of medical staff is greatly reduced, the detection and analysis of the kidney cancer patient can be suitable for diabetic complications, bladder cancer, prostate cancer and breast cancer, and the accuracy of sample detection data is greatly improved through the comparative analysis of multiple groups of data. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115448489-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115448489-B |
priorityDate | 2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.